questionsmedicales.fr
Bactéries
Proteobacteria
Gammaproteobacteria
Vibrionaceae
Vibrionaceae : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Infections bactériennes
Culture bactérienne
Tests sérologiques
Infections bactériennes
Caractéristiques morphologiques
Tests biochimiques
Symptômes
5
Déshydratation
Choc hypovolémique
Infections asymptomatiques
Porteurs sains
Prévention
5
Sécurité alimentaire
Fruits de mer
Voyage
Précautions sanitaires
Hygiène des mains
Prévention des infections
Traitements
5
Antibiotiques
Infections bactériennes
Solutions de réhydratation
Déshydratation
Traitements symptomatiques
Antiémétiques
Complications
5
Déshydratation
Insuffisance rénale
Choléra
Choc hypovolémique
Infections mortelles
Vulnérabilité
Gestion des complications
Réhydratation
Personnes âgées
Complications
Facteurs de risque
5
Fruits de mer
Eau contaminée
Immunodépression
Infections graves
Climat
Infections bactériennes
Voyages
Risque d'infection
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vibrionaceae : Questions médicales les plus fréquentes",
"headline": "Vibrionaceae : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vibrionaceae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-17",
"dateModified": "2025-03-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vibrionaceae"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Gammaproteobacteria",
"url": "https://questionsmedicales.fr/mesh/D020563",
"about": {
"@type": "MedicalCondition",
"name": "Gammaproteobacteria",
"code": {
"@type": "MedicalCode",
"code": "D020563",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aliivibrio",
"alternateName": "Aliivibrio",
"url": "https://questionsmedicales.fr/mesh/D059706",
"about": {
"@type": "MedicalCondition",
"name": "Aliivibrio",
"code": {
"@type": "MedicalCode",
"code": "D059706",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.050"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aliivibrio fischeri",
"alternateName": "Aliivibrio fischeri",
"url": "https://questionsmedicales.fr/mesh/D048908",
"about": {
"@type": "MedicalCondition",
"name": "Aliivibrio fischeri",
"code": {
"@type": "MedicalCode",
"code": "D048908",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.050.860"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Aliivibrio salmonicida",
"alternateName": "Aliivibrio salmonicida",
"url": "https://questionsmedicales.fr/mesh/D044165",
"about": {
"@type": "MedicalCondition",
"name": "Aliivibrio salmonicida",
"code": {
"@type": "MedicalCode",
"code": "D044165",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.050.930"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Listonella",
"alternateName": "Listonella",
"url": "https://questionsmedicales.fr/mesh/D053526",
"about": {
"@type": "MedicalCondition",
"name": "Listonella",
"code": {
"@type": "MedicalCode",
"code": "D053526",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Photobacterium",
"alternateName": "Photobacterium",
"url": "https://questionsmedicales.fr/mesh/D010776",
"about": {
"@type": "MedicalCondition",
"name": "Photobacterium",
"code": {
"@type": "MedicalCode",
"code": "D010776",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.590"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio",
"alternateName": "Vibrio",
"url": "https://questionsmedicales.fr/mesh/D014733",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio",
"code": {
"@type": "MedicalCode",
"code": "D014733",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vibrio alginolyticus",
"alternateName": "Vibrio alginolyticus",
"url": "https://questionsmedicales.fr/mesh/D044149",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio alginolyticus",
"code": {
"@type": "MedicalCode",
"code": "D044149",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.030"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae",
"alternateName": "Vibrio cholerae",
"url": "https://questionsmedicales.fr/mesh/D014734",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae",
"code": {
"@type": "MedicalCode",
"code": "D014734",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae non-O1",
"alternateName": "Vibrio cholerae non-O1",
"url": "https://questionsmedicales.fr/mesh/D044163",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae non-O1",
"code": {
"@type": "MedicalCode",
"code": "D044163",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O1",
"alternateName": "Vibrio cholerae O1",
"url": "https://questionsmedicales.fr/mesh/D041241",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O1",
"code": {
"@type": "MedicalCode",
"code": "D041241",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.151"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O139",
"alternateName": "Vibrio cholerae O139",
"url": "https://questionsmedicales.fr/mesh/D041242",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O139",
"code": {
"@type": "MedicalCode",
"code": "D041242",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae non-O1",
"alternateName": "Vibrio cholerae non-O1",
"url": "https://questionsmedicales.fr/mesh/D044163",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae non-O1",
"code": {
"@type": "MedicalCode",
"code": "D044163",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O1",
"alternateName": "Vibrio cholerae O1",
"url": "https://questionsmedicales.fr/mesh/D041241",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O1",
"code": {
"@type": "MedicalCode",
"code": "D041241",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.151"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O139",
"alternateName": "Vibrio cholerae O139",
"url": "https://questionsmedicales.fr/mesh/D041242",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O139",
"code": {
"@type": "MedicalCode",
"code": "D041242",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio mimicus",
"alternateName": "Vibrio mimicus",
"url": "https://questionsmedicales.fr/mesh/D044164",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio mimicus",
"code": {
"@type": "MedicalCode",
"code": "D044164",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio parahaemolyticus",
"alternateName": "Vibrio parahaemolyticus",
"url": "https://questionsmedicales.fr/mesh/D014736",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio parahaemolyticus",
"code": {
"@type": "MedicalCode",
"code": "D014736",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.590"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio vulnificus",
"alternateName": "Vibrio vulnificus",
"url": "https://questionsmedicales.fr/mesh/D041261",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio vulnificus",
"code": {
"@type": "MedicalCode",
"code": "D041261",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.900"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vibrionaceae",
"alternateName": "Vibrionaceae",
"code": {
"@type": "MedicalCode",
"code": "D014737",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Chunqi Jiang",
"url": "https://questionsmedicales.fr/author/Chunqi%20Jiang",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Microbiology, Faculty of Fisheries Sciences, Hokkaido University, Hakodate, Japan."
}
},
{
"@type": "Person",
"name": "Sayaka Mino",
"url": "https://questionsmedicales.fr/author/Sayaka%20Mino",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Microbiology, Faculty of Fisheries Sciences, Hokkaido University, Hakodate, Japan."
}
},
{
"@type": "Person",
"name": "Jesús L Romalde",
"url": "https://questionsmedicales.fr/author/Jes%C3%BAs%20L%20Romalde",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Microbiología y Parasitología, CRETUS & CIBUS-Facultad de Biología, Universidade de Santiago de Compostela, Campus Vida, Santiago de Compostela, España."
}
},
{
"@type": "Person",
"name": "Tomoo Sawabe",
"url": "https://questionsmedicales.fr/author/Tomoo%20Sawabe",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Microbiology, Faculty of Fisheries Sciences, Hokkaido University, Hakodate, Japan. sawabe@fish.hokudai.ac.jp."
}
},
{
"@type": "Person",
"name": "William Soto",
"url": "https://questionsmedicales.fr/author/William%20Soto",
"affiliation": {
"@type": "Organization",
"name": "Integrated Science Center Rm 3035, Department of Biology, College of William & Mary, 540 Landrum Dr., Williamsburg, VA 23185, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Hemoperfusion in Poisoning and Drug Overdose.",
"datePublished": "2023-06-13",
"url": "https://questionsmedicales.fr/article/37311422",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000526730"
}
},
{
"@type": "ScholarlyArticle",
"name": "Educational Attainment and US Drug Overdose Deaths.",
"datePublished": "2023-10-06",
"url": "https://questionsmedicales.fr/article/37801307",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamahealthforum.2023.3274"
}
},
{
"@type": "ScholarlyArticle",
"name": "Psychological distress and the risk of drug overdose death.",
"datePublished": "2022-08-31",
"url": "https://questionsmedicales.fr/article/36057284",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jad.2022.08.115"
}
},
{
"@type": "ScholarlyArticle",
"name": "Drug Decriminalization, Fentanyl, and Fatal Overdoses in Oregon.",
"datePublished": "2024-09-03",
"url": "https://questionsmedicales.fr/article/39235814",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2024.31612"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of drug overdoses and user characteristics of Canada's national mobile/virtual overdose response hotline: the National Overdose Response Service (NORS).",
"datePublished": "2023-09-27",
"url": "https://questionsmedicales.fr/article/37752527",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12889-023-16751-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Bactéries",
"item": "https://questionsmedicales.fr/mesh/D001419"
},
{
"@type": "ListItem",
"position": 3,
"name": "Proteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020560"
},
{
"@type": "ListItem",
"position": 4,
"name": "Gammaproteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020563"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vibrionaceae",
"item": "https://questionsmedicales.fr/mesh/D014737"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vibrionaceae - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vibrionaceae",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vibrionaceae",
"description": "Comment diagnostiquer une infection par Vibrionaceae ?\nQuels tests sont utilisés pour identifier Vibrio cholerae ?\nLes tests sérologiques sont-ils utiles pour Vibrionaceae ?\nQuels symptômes indiquent une infection vibrionique ?\nComment différencier Vibrionaceae d'autres bactéries ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Drug+Overdose#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vibrionaceae",
"description": "Quels sont les symptômes courants d'une infection par Vibrionaceae ?\nLes infections vibrioniques causent-elles des vomissements ?\nY a-t-il des symptômes graves associés aux Vibrionaceae ?\nLes symptômes apparaissent-ils rapidement après infection ?\nLes infections vibrioniques peuvent-elles être asymptomatiques ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Drug+Overdose#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vibrionaceae",
"description": "Comment prévenir les infections par Vibrionaceae ?\nLes vaccins existent-ils contre Vibrionaceae ?\nQuelles mesures de sécurité alimentaire sont recommandées ?\nLes voyageurs doivent-ils prendre des précautions ?\nL'hygiène des mains est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Drug+Overdose#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vibrionaceae",
"description": "Quel est le traitement principal pour les infections par Vibrionaceae ?\nLes antibiotiques sont-ils nécessaires pour traiter Vibrionaceae ?\nComment prévenir la déshydratation dans les infections vibrioniques ?\nLes traitements symptomatiques sont-ils efficaces ?\nY a-t-il des traitements spécifiques pour le choléra ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Drug+Overdose#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vibrionaceae",
"description": "Quelles complications peuvent survenir avec Vibrionaceae ?\nLe choléra peut-il entraîner des complications graves ?\nLes infections vibrioniques peuvent-elles être mortelles ?\nComment les complications sont-elles gérées ?\nLes personnes âgées sont-elles plus à risque de complications ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Drug+Overdose#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vibrionaceae",
"description": "Quels sont les principaux facteurs de risque d'infection ?\nLes personnes immunodéprimées sont-elles à risque ?\nLe climat influence-t-il le risque d'infection ?\nLes enfants sont-ils plus vulnérables ?\nLes voyages dans certaines régions augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Drug+Overdose#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Vibrionaceae ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par culture bactérienne à partir d'échantillons de selles."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier Vibrio cholerae ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques et des méthodes moléculaires comme la PCR sont utilisés."
}
},
{
"@type": "Question",
"name": "Les tests sérologiques sont-ils utiles pour Vibrionaceae ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils ne sont généralement pas utilisés pour le diagnostic des infections vibrioniques."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection vibrionique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la diarrhée, les vomissements et la déshydratation peuvent indiquer une infection."
}
},
{
"@type": "Question",
"name": "Comment différencier Vibrionaceae d'autres bactéries ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse des caractéristiques morphologiques et des tests biochimiques aide à la différenciation."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une infection par Vibrionaceae ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent diarrhée aqueuse, crampes abdominales et fièvre."
}
},
{
"@type": "Question",
"name": "Les infections vibrioniques causent-elles des vomissements ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vomissements sont fréquents, surtout dans les cas de choléra."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes graves associés aux Vibrionaceae ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes graves incluent la déshydratation sévère et le choc hypovolémique."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement après infection ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent apparaître rapidement, souvent dans les 24 heures."
}
},
{
"@type": "Question",
"name": "Les infections vibrioniques peuvent-elles être asymptomatiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent être asymptomatiques, surtout chez les porteurs sains."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par Vibrionaceae ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une bonne hygiène, la cuisson des aliments et l'eau potable."
}
},
{
"@type": "Question",
"name": "Les vaccins existent-ils contre Vibrionaceae ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un vaccin contre le choléra est disponible, mais pas pour toutes les espèces de Vibrionaceae."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité alimentaire sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de bien cuire les fruits de mer et de ne pas consommer d'eau non traitée."
}
},
{
"@type": "Question",
"name": "Les voyageurs doivent-ils prendre des précautions ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyageurs vers des zones à risque doivent être prudents avec l'eau et la nourriture."
}
},
{
"@type": "Question",
"name": "L'hygiène des mains est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, se laver les mains régulièrement est crucial pour prévenir les infections."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour les infections par Vibrionaceae ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réhydratation orale ou intraveineuse est le traitement principal, surtout pour le choléra."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils nécessaires pour traiter Vibrionaceae ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques peuvent être prescrits dans les cas graves, mais ne sont pas toujours nécessaires."
}
},
{
"@type": "Question",
"name": "Comment prévenir la déshydratation dans les infections vibrioniques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'administration rapide de solutions de réhydratation est essentielle pour prévenir la déshydratation."
}
},
{
"@type": "Question",
"name": "Les traitements symptomatiques sont-ils efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements symptomatiques comme les antiémétiques peuvent aider à soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements spécifiques pour le choléra ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antibiotiques spécifiques et des solutions de réhydratation sont recommandés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec Vibrionaceae ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent la déshydratation sévère, le choc et l'insuffisance rénale."
}
},
{
"@type": "Question",
"name": "Le choléra peut-il entraîner des complications graves ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le choléra peut entraîner des complications graves comme le choc hypovolémique."
}
},
{
"@type": "Question",
"name": "Les infections vibrioniques peuvent-elles être mortelles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement approprié, les infections peuvent être mortelles, surtout chez les vulnérables."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont gérées par une réhydratation rapide et un traitement médical approprié."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque de complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées sont plus susceptibles de développer des complications graves."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent la consommation de fruits de mer crus et l'eau contaminée."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées courent un risque accru d'infections graves."
}
},
{
"@type": "Question",
"name": "Le climat influence-t-il le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections par Vibrionaceae sont plus fréquentes dans les climats chauds et humides."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus vulnérables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus vulnérables aux infections et à leurs complications."
}
},
{
"@type": "Question",
"name": "Les voyages dans certaines régions augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions à risque augmente la probabilité d'infection par Vibrionaceae."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 14/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Laboratory of Microbiology, Faculty of Fisheries Sciences, Hokkaido University, Hakodate, Japan.
Publications dans "Vibrionaceae" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Microbiology, Faculty of Fisheries Sciences, Hokkaido University, Hakodate, Japan.
Publications dans "Vibrionaceae" :
2 publications dans cette catégorie
Affiliations :
Departamento de Microbiología y Parasitología, CRETUS & CIBUS-Facultad de Biología, Universidade de Santiago de Compostela, Campus Vida, Santiago de Compostela, España.
Publications dans "Vibrionaceae" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Microbiology, Faculty of Fisheries Sciences, Hokkaido University, Hakodate, Japan. sawabe@fish.hokudai.ac.jp.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Integrated Science Center Rm 3035, Department of Biology, College of William & Mary, 540 Landrum Dr., Williamsburg, VA 23185, USA.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, Faculty of Science, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, Faculty of Science, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, Faculty of Science, Universiti Putra Malaysia, and Laboratory of Marine Biotechnology, Institute of Bioscience, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Department of Veterinary Laboratory Diagnosis, Faculty of Veterinary Medicine, Universiti Putra Malaysia, and Laboratory of Marine Biotechnology, Institute of Bioscience, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Department of Aquaculture, Faculty of Agriculture, Universiti Putra Malaysia, and Laboratory of Marine Biotechnology, Institute of Bioscience, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Laboratory of Marine Biotechnology, Institute of Bioscience, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
International Institute for Halal Research and Training, International Islamic University Malaysia, 53100 Gombak, Selangor, Malaysia.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid 28040, Spain.
VISAVET Health Surveillance Centre, Universidad Complutense de Madrid, Madrid 28040, Spain.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid 28040, Spain.
VISAVET Health Surveillance Centre, Universidad Complutense de Madrid, Madrid 28040, Spain.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid 28040, Spain.
VISAVET Health Surveillance Centre, Universidad Complutense de Madrid, Madrid 28040, Spain.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid 28040, Spain.
VISAVET Health Surveillance Centre, Universidad Complutense de Madrid, Madrid 28040, Spain.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CNB-CSIC), Madrid 28049, Spain.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid 28040, Spain.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid 28040, Spain.
VISAVET Health Surveillance Centre, Universidad Complutense de Madrid, Madrid 28040, Spain.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CNB-CSIC), Madrid 28049, Spain.
Centro de Investigación Biológica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid 28222, Spain.
Publications dans "Vibrionaceae" :
1 publication dans cette catégorie
Affiliations :
Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid 28040, Spain.
VISAVET Health Surveillance Centre, Universidad Complutense de Madrid, Madrid 28040, Spain.
Publications dans "Vibrionaceae" :
Hemoperfusion (HP) is an extracorporeal blood purification therapy that is used to remove poisons or drugs from the body. This chapter provides a brief overview of the technical aspects and the potent...
Educational attainment in the US is associated with life expectancy. As the opioid crisis worsens, it is critical to understand how overdose death rate trends evolve across education groups....
To investigate the association between educational attainment and overdose death rates, with emphasis on trends during the COVID-19 pandemic....
This cross-sectional study used National Vital Statistics System Mortality Multiple Cause-of-Death data describing overdose death rates in the US by educational attainment from January 1, 2000, to Dec...
Educational attainment, categorized as no high school (HS) diploma, HS diploma (or General Educational Development) but no college, some college but no bachelor's degree, and bachelor's degree or more...
The main outcomes were rates of all overdose deaths, overdose deaths involving opioids, and overdose deaths involving synthetic opioids....
Of 912 057 overdose deaths with education information from 2000 to 2021 (mean [SD] age at death, 44.9 [12.3] years; 64.1% male), there were 625 400 deaths (68.6%) among individuals with no college edu...
In this cross-sectional study, lower educational attainment was found to be associated with higher growth in overdose deaths. As the opioid crisis has transitioned to fentanyl and polysubstance use, o...
Previous research has shown an association between psychological distress and overdose death among specific populations. However, few studies have examined this relationship in a large US population-b...
Data from the 2010-2018 NHIS were linked to mortality data from the National Death Index through 2019. Psychological distress was measured using the Kessler 6 scale. Drug overdose deaths were examined...
The study population included 272,561 adults. Adjusting for demographic covariates and using no psychological distress as the reference, distress level was positively associated with the risk of overd...
Limited substance use information prevented adjustment for this potentially important covariate....
Adults with psychological distress were at greater risk of drug overdose death, relative to those without psychological distress. Adults with psychological distress were also at increased risk of deat...
With the implementation of Measure 110 (M110) in 2021, Oregon became the first US state to decriminalize small amounts of any drug for personal use. To date, no analysis of the association of this law...
To evaluate whether the decriminalization of drug possession in Oregon was associated with changes in fatal drug overdose rates after accounting for the rapid spread of fentanyl in Oregon's unregulate...
In this cohort study, the association between fatal overdose and enactment of M110 was analyzed using a matrix completion synthetic control method. The control group consisted of the 48 US states and ...
Measure 110 took effect in Oregon on February 1, 2021....
The primary outcome assessed was fatal drug overdose rates per half-year. A changepoint analysis also determined when each state experienced a rapid escalation of fentanyl in its unregulated drug mark...
In this analysis, rapid spread of fentanyl in Oregon's unregulated drug supply occurred in the first half of 2021, contemporaneous with enactment of M110. A positive crude association was found betwee...
In this cohort study of fatal drug overdose and the spread of fentanyl through Oregon's unregulated drug market, no association between M110 and fatal overdose rates was observed. Future evaluations o...
Several novel overdose response technology interventions, also known as mobile overdose response services (MORS), have emerged as adjunct measures to reduce the harms associated with the drug poisonin...
A retrospective analysis was conducted using NORS call logs from December 2020 to April 2023 imputed by operators. A variety of variables were examined including demographics, substance use and route,...
Of the 6528 completed calls on the line, 3994 (61.2%) were for supervised drug consumption, 1703 (26.1%) were for mental health support, 354 (5.42%) were for harm reduction education or resources, and...
NORS presents a complimentary opportunity to access harm reduction services for individuals that prefer to use alone or face barriers to accessing in-person supervised consumption services especially ...
Death certificates provide incomplete information on the specific drug categories involved in fatal overdoses. The accuracy of previously developed corrections for this and modifications to them was e...
Data were obtained for the universe of 932,364 drug overdoses in the U.S. between 1999 and 2020, including 769,982 (82.6%) with a drug classification and 162,382 (17.4%) without, from the National Cen...
Previous regression-based corrections that controlled for decedent characteristics can be improved upon by adding state-fixed effects as covariates. Once this is done, supplementary controls for count...
Failing to correct for incomplete information on death certificates leads to inaccurate counts of deaths from specific categories of drugs, such as opioids. However, relatively simple corrections are ...
U.S. drug-related overdose deaths and Emergency Department (ED) visits rose in 2020 and again in 2021. Many academic studies and the news media attributed this rise primarily to increased drug use res...
We use national data from the Centers for Disease Control and Prevention (CDC) on rolling 12-month drug-related deaths (2015-2021); CDC data on monthly ED visits (2019-September 2020) for EDs in 42 st...
Mortality. National overdose mortality increased from 21/100,000 in 2019 to 26/100,000 in 2020 and 30/100,000 in 2021. The rise in mortality began in mid-to-late half of 2019, and the 2020 increase is...
The reasons for rising overdose mortality in 2020 and 2021 cannot be definitely determined. We lack a control group and thus cannot assess causation. However, the observed increases can be largely exp...
This study estimated years of life lost (YLL) among US Latinx individuals during the most recent wave of drug overdose deaths....
A serial cross-sectional study of YLL (life expectancy minus age at death) from death certificate records of Latinx individuals who died from drug overdoses from 2015 to mid-2022....
Over the study period, 58,209 Latinx individuals aged 15-64 years died from drug overdoses resulting in 2,266,784 YLL. Age-group YLL differences remained stable, but gender YLL trajectories diverged....
This study extends our understanding of the immense loss to Latinx communities from preventable drug deaths....
Pharmaceutical opioid dosage forms are commonly misused via an oral route in non-manipulated form, i.e., overdose in intact form, or manipulated form, i.e., after crushing the dosage form, and also vi...
Slow and incremental changes in federal and state drug policies are neither meeting treatment needs nor reversing yearly increases in drug-related mortality. U.S. drug policies convey confounding mess...